3Muirhead N ,Bargman J,Burgess E,et al. Evidence-based recommendations for the clinical use of recombinant human erythropoietin. Am J Kidney Dis, 1995(supple 1 ):1.
4Hon G,Vaziri ND,Kaupke CJ,et al.Lack of a fast-acting effect of erythropoietin on arterial blood pressure and endothelin level. Artif Organs. 1995,19:188.
5Lebel M,Kingma I,Grose H,et al.Hemodynamic and hormonal changes during erythropoietin therapy in hemodialysis patients[].Journal of the American Society of Nephrology.1998
6Mombouli V,Vanhoutte M.Endothelial dysfunction from physiology to therapy[].Journal of Molecular and Cellular Cardiology.1999
7Reverter C,Cases A,Calls J,et al.Effect of recombinant human erythropoietin treatment on circulating reticulated platelets in uremic patients: association with early improvement in platelet function[].American Journal of Hematology.1998
8Ruskoaho H.Artrial nartiuretic peptide: synthesis, release and metabolism[].Pharmacology Reviews.1992
